Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease

J Emerg Med. 2007 Feb;32(2):209-10; author reply 210. doi: 10.1016/j.jemermed.2006.12.005. Epub 2007 Jan 22.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Crohn Disease / drug therapy*
  • Humans
  • Hypersensitivity, Delayed / chemically induced*
  • Hypersensitivity, Delayed / immunology
  • Infliximab
  • Male
  • Serum Sickness / chemically induced*
  • Serum Sickness / immunology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab